We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
BIOGLAN MEN’S DAILY ADAPT WITH SIBERIAN GINSENG & REISHI (Natural Bio Pty Limited)
Product Name
BIOGLAN MEN’S DAILY ADAPT WITH SIBERIAN GINSENG & REISHI
Sponsor
ARTG details
- 378590
Date of review outcome
Date of publication
Jun-2025
Outcome
Medicine is no longer permitted to be supplied
Is it safe to continue using this medicine?
Yes, based on the sponsor’s certification. However, follow the recommended actions below.
What action should consumers take?
Consider whether this medicine is right for you given the claim for supporting physical endurance when dietary intake is inadequate was not substantiated by the sponsor.
Be aware that this medicine may not work as expected in relation to relieving symptoms of mild anxiety, promoting better sleep quality, relieving muscle aches and cramps, maintaining muscle mass and aiding muscle recovery.
Be aware that this medicine may not work as expected in relation to relieving symptoms of mild anxiety, promoting better sleep quality, relieving muscle aches and cramps, maintaining muscle mass and aiding muscle recovery.
Review scope
Targeted (see Additional Information below)
Information reviewed
ARTG Record, Evidence, Labels, Website
Issues related to safety
None
Issues related to efficacy
The sponsor did not hold sufficient evidence to support the claim relating to supporting physical endurance when dietary intake is inadequate. The limitations with the evidence included the dosage, and results of the studies not being relevant to this medicine. The website for this medicine also contained claims specified in ‘What action should consumers take?’ above. However, these claims were not covered by the sponsor’s certification that they held evidence to substantiate them.
Actions taken during the review
The sponsor cancelled this medicine and withdrew it from further supply. Nevertheless, the TGA issued an educational letter to the sponsor outlining the issues with this medicine.
Additional information
This medicine was targeted to check its compliance in relation to claims about exercise, muscle, or physical performance